A

Agilent Technologies Inc. Common Stock (A)

Stock · NYSE · Industrials

$153.78as of 8/28/2026

AI Market Commentary

AI-generated

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

August 30, 2026

Agilent Gets Lift From Wall Street as Multiple Brokers Hike Price Targets. At least seven brokerages, including Stifel, Citigroup, JP Morgan, TD Cowen, Bernstein, and RBC Capital, raised their price targets on Agilent Technologies this week, with new targets reaching as high as $190. The moves follow a Seeking Alpha piece highlighting the company's third-quarter growth, expanding margins, and raised guidance. Together, the upgrades suggest analysts see the recent results as a positive development for the stock, which trades near the upper end of its 52-week range and has shown elevated trading activity.

Active signals

Support level
$111.09
Industry
Biotechnology: Laboratory Analytical Instruments

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems.…

Sector
Industrials
Industry
Biotechnology: Laboratory Analytical Instruments
Employees
18,000

Fundamentals

1-day range
$150$155.77
Market cap
$39.92B
P/E (trailing)
29.37
P/E (forward)
23.50
EPS (trailing)
$4.97
Dividend yield
0.75%
Beta
1.24
Avg. volume
2.26M
Ex-dividend date
June 30, 2026
Dividend pay date
July 22, 2026
52-week range
$108.35$163.75
Next earnings: August 26, 2026 · EPS estimate $1.49After Closeconfirmed

How Agilent Technologies Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$6.95BNet Income$1.30B (19%)Cost of Revenue$3.31B (48%)SG&A$1.71B (25%)R&D$455.00M (7%)Tax$132.00M (2%)Other$44.00M (1%)A

Source: 10-K filed Dec 22, 2025 · via SEC EDGAR / Finnhub

Forecasts

19 analyst ratings

Buy 76%
Hold 24%
Sell 0%
1-year price forecast
High
$185
+20.3%
Median
$159
+3.4%
Low
$135
-12.2%

Agilent Technologies Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • A
    Agilent Technologies Inc. Common Stock
    $153.84
    ▼ 2.44%
    Market cap $39.92BP/E 29.37
    $108.35$163.75
  • RVTY
    Revvity Inc. Common Stock
    $128.8
    ▼ 0.70%
    Market cap $12.74BP/E 55.10
    $81.22$129.8
  • TXG
    10x Genomics Inc. Class A Common Stock
    $61.55
    ▼ 5.10%
    Market cap $5.79BP/E
    $11.16$66.94
  • ALMR
    Alamar Biosciences Inc. Common Stock
    $30.71
    ▼ 6.94%
    Market cap $1.95BP/E
    $18.85$38.54
  • EYPT
    EyePoint Inc. Common Stock
    $4.47
    ▼ 3.46%
    Market cap $1.08BP/E
    $3.95$19.11
  • CTKB
    Cytek Biosciences Inc. Common Stock
    $4.69
    ▲ 1.41%
    Market cap $537.23MP/E
    $3.28$6.18
  • PACB
    Pacific Biosciences of California Inc. Common Stock
    $1.4
    ▼ 10.00%
    Market cap $361.85MP/E
    $1.07$2.73

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
23.8K
Disposed
3.8K

Institutional Ownership

March 31, 2026

Total shares held
234.50M
Total value held
$24.91B
Institutional holders
1047
Top holders this quarter
  • Unknown25.90M
  • Unknown18.38M
  • Unknown12.76M
  • Unknown12.62M
  • Unknown8.99M
  • Unknown7.52M
  • Unknown7.26M
  • Unknown5.98M
  • Unknown4.95M
  • Unknown3.83M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.